Literature DB >> 12196327

Persistent infarct-related artery occlusion is associated with an increased myocardial apoptosis at postmortem examination in humans late after an acute myocardial infarction.

Antonio Abbate1, Rossana Bussani, Giuseppe G L Biondi-Zoccai, Raffaele Rossiello, Furio Silvestri, Feliciano Baldi, Luigi M Biasucci, Alfonso Baldi.   

Abstract

BACKGROUND: Myocardial apoptosis persists beyond the acute phases of acute myocardial infarction (AMI) and is associated with left ventricular (LV) remodeling. Infarct-related artery (IRA) patency is considered a favorable prognostic factor after AMI and may be associated with more favorable LV remodeling because of reduced apoptosis at the site of AMI. The aim of this study was to assess the influence of IRA status on apoptotic rate (AR) in the hearts of subjects dying late after AMI. METHODS AND
RESULTS: We used colocalization for in situ end-labeling of DNA fragmentation and immunohistochemistry for caspase-3 to calculate the AR at time of death (12 to 62 days after AMI) in 16 hearts with persistently occluded IRAs and in 8 hearts with patent IRAs. No significant differences were found when comparing the clinical characteristics of the 2 groups. Occluded IRA was associated with significantly higher AR at site of infarction (25.8% [interquartile range 20.9% to 28.5%] versus 2.3% [interquartile range 0.6% to 5.0%], P<0.001). This strong correlation between IRA occlusion and AR remained statistically significant even after correction for clinical characteristics such as sex, age, history of previous additional AMI or heart failure, transmural AMI, anterior AMI, fibrinolytic treatment, time from AMI to death, trauma as cause of death, and multivessel coronary disease (P=0.003).
CONCLUSIONS: A significantly higher AR was associated with persistent IRA occlusion late post-AMI. These data may suggest that the post-AMI benefits observed with a patent IRA (the "open-artery hypothesis") may in part be due to reduced myocardial apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196327     DOI: 10.1161/01.cir.0000030936.97158.c4

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

1.  Altered oxido-reductive state in the diabetic heart: loss of cardioprotection due to protein disulfide isomerase.

Authors:  Stefano Toldo; Mariarosaria Boccellino; Barbara Rinaldi; Ignacio M Seropian; Eleonora Mezzaroma; Anna Severino; Lucio Quagliuolo; Benjamin W Van Tassell; Raffaele Marfella; Giuseppe Paolisso; Francesco Rossi; Ramesh Natarajan; Norbert Voelkel; Antonio Abbate; Filippo Crea; Alfonso Baldi
Journal:  Mol Med       Date:  2011-05-31       Impact factor: 6.354

2.  Cyclo-oxygenase-2 (COX-2) expression at the site of recent myocardial infarction: friend or foe?

Authors:  A Abbate; D Santini; G G L Biondi-Zoccai; S Scarpa; F Vasaturo; G Liuzzo; R Bussani; F Silvestri; F Baldi; F Crea; L M Biasucci; A Baldi
Journal:  Heart       Date:  2004-04       Impact factor: 5.994

3.  Infarct zone viability influences ventricular remodelling after late recanalisation of an occluded infarct related artery.

Authors:  N G Bellenger; Z Yousef; K Rajappan; M S Marber; D J Pennell
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

Review 4.  Role of various proteases in cardiac remodeling and progression of heart failure.

Authors:  Alison L Müller; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 5.  Can heart function lost to disease be regenerated by therapeutic targeting of cardiac scar tissue?

Authors:  Emily L Ongstad; Robert G Gourdie
Journal:  Semin Cell Dev Biol       Date:  2016-05-24       Impact factor: 7.727

6.  Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy.

Authors:  P Di Napoli; A A Taccardi; A Barsotti
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

7.  Distinctive ERK and p38 signaling in remote and infarcted myocardium during post-MI remodeling in the mouse.

Authors:  Che-Chung Yeh; Hongzhe Li; Deepak Malhotra; Sally Turcato; Susan Nicholas; Richard Tu; Bo-Qing Zhu; John Cha; Philip M Swigart; Bat-Erdene Myagmar; Anthony J Baker; Paul C Simpson; Michael J Mann
Journal:  J Cell Biochem       Date:  2010-04-15       Impact factor: 4.429

8.  Cell therapy generates a favourable chemokine gradient for stem cell recruitment into the infarcted heart in rabbits.

Authors:  Bai-Chin Lee; Hsiu-Ching Hsu; Wen-Yih I Tseng; Ching-Yi Chen; Hung-Ju Lin; Yi-Lwun Ho; Ming-Jai Su; Ming-Fong Chen
Journal:  Eur J Heart Fail       Date:  2009-01-12       Impact factor: 15.534

9.  Right ventricular dilatation after left ventricular acute myocardial infarction is predictive of extremely high peri-infarctual apoptosis at postmortem examination in humans.

Authors:  R Bussani; A Abbate; G G L Biondi-Zoccai; A Dobrina; A M Leone; D Camilot; M P Di Marino; F Baldi; F Silvestri; L M Biasucci; A Baldi
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

Review 10.  Cell therapy with bone marrow cells for myocardial regeneration.

Authors:  Hyongbum Kim; Sung-Whan Kim; Douglas Nam; Sinae Kim; Young-Sup Yoon
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.